The Clorox Company $CLX Shares Bought by Northern Trust Corp

Key Points

• Northern Trust Corp has increased its holdings in Clorox by 2.3%, owning approximately 1.24% of the company, valued at $225 million.
• Clorox's stock is currently rated mostly as "neutral" with a consensus price target of $143.36, reflecting recent adjustments from various analysts.
• The company has announced a quarterly dividend increase to $1.24 per share, providing a 4.1% yield—a rise from the previous dividend of $1.22.

Northern Trust Corp boosted its holdings in shares of The Clorox Company (NYSE:CLX - Free Report) by 2.3% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,528,920 shares of the company's stock after purchasing an additional 34,655 shares during the period. Northern Trust Corp owned about 1.24% of Clorox worth $225,133,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in CLX. Dimensional Fund Advisors LP lifted its position in Clorox by 11.2% during the fourth quarter. Dimensional Fund Advisors LP now owns 931,028 shares of the company's stock valued at $151,202,000 after purchasing an additional 93,570 shares during the period. State of Tennessee Department of Treasury raised its position in shares of Clorox by 69.8% in the fourth quarter. State of Tennessee Department of Treasury now owns 38,455 shares of the company's stock worth $6,245,000 after acquiring an additional 15,810 shares during the period. Hsbc Holdings PLC raised its position in shares of Clorox by 7.5% in the fourth quarter. Hsbc Holdings PLC now owns 496,117 shares of the company's stock worth $80,474,000 after acquiring an additional 34,703 shares during the period. Price T Rowe Associates Inc. MD raised its position in shares of Clorox by 41.7% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 554,688 shares of the company's stock worth $90,088,000 after acquiring an additional 163,341 shares during the period. Finally, MGO One Seven LLC raised its position in shares of Clorox by 65.5% in the fourth quarter. MGO One Seven LLC now owns 2,682 shares of the company's stock worth $436,000 after acquiring an additional 1,061 shares during the period. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

CLX has been the subject of a number of analyst reports. Citigroup reiterated a "neutral" rating and issued a $135.00 price objective (down previously from $140.00) on shares of Clorox in a research report on Tuesday, July 15th. UBS Group decreased their price objective on shares of Clorox from $150.00 to $134.00 and set a "neutral" rating for the company in a research report on Thursday, July 17th. Evercore ISI set a $140.00 price objective on shares of Clorox and gave the stock an "underperform" rating in a research report on Tuesday, May 6th. Wells Fargo & Company upped their price objective on shares of Clorox from $135.00 to $138.00 and gave the stock an "equal weight" rating in a research report on Friday, August 1st. Finally, Jefferies Financial Group decreased their price objective on shares of Clorox from $167.00 to $145.00 and set a "buy" rating for the company in a research report on Thursday, June 26th. One research analyst has rated the stock with a Buy rating, eight have assigned a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Reduce" and an average price target of $143.36.

Clorox Stock Down 1.2%

CLX stock opened at $119.8040 on Friday. The stock has a market capitalization of $14.65 billion, a P/E ratio of 18.37, a P/E/G ratio of 0.97 and a beta of 0.49. The firm has a 50-day simple moving average of $124.31 and a 200-day simple moving average of $135.57. The company has a quick ratio of 0.57, a current ratio of 0.84 and a debt-to-equity ratio of 5.15. The Clorox Company has a 52 week low of $117.35 and a 52 week high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last released its earnings results on Thursday, July 31st. The company reported $2.87 EPS for the quarter, topping analysts' consensus estimates of $2.24 by $0.63. The business had revenue of $1.99 billion during the quarter, compared to analysts' expectations of $1.94 billion. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The company's quarterly revenue was up 4.5% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.82 earnings per share. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. Equities analysts forecast that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 29th. Investors of record on Wednesday, August 13th will be paid a dividend of $1.24 per share. The ex-dividend date of this dividend is Wednesday, August 13th. This represents a $4.96 annualized dividend and a yield of 4.1%. This is a boost from Clorox's previous quarterly dividend of $1.22. Clorox's dividend payout ratio is currently 76.07%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.